227 related articles for article (PubMed ID: 6107379)
1. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.
Boxenbaum H
J Pharmacokinet Biopharm; 1980 Apr; 8(2):165-76. PubMed ID: 6107379
[TBL] [Abstract][Full Text] [Related]
2. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
[TBL] [Abstract][Full Text] [Related]
3. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
4. Interspecies scaling of the pharmacokinetic parameters of coumarin among six different mammalian species.
Ritschel WA; Vachharajani NN; Johnson RD; Hussain AS
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):697-702. PubMed ID: 1770833
[TBL] [Abstract][Full Text] [Related]
5. Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species.
Boxenbaum H; Fertig JB
Eur J Drug Metab Pharmacokinet; 1984; 9(2):177-83. PubMed ID: 6745307
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
Van Peer A; Belpaire F; Bogaert M
Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
[TBL] [Abstract][Full Text] [Related]
7. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in uraemic rabbits.
Van Peer AP; Belpaire FM; Bogaert MG
J Pharm Pharmacol; 1980 Feb; 32(2):135-6. PubMed ID: 6103036
[No Abstract] [Full Text] [Related]
8. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
van Peer AP; Belpaire FM; Bogaert MG
Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
[No Abstract] [Full Text] [Related]
9. Drug kinetics and alcohol ingestion.
Sellers EM; Holloway MR
Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
[TBL] [Abstract][Full Text] [Related]
10. Value of field data for extrapolation in anthrax.
Lincoln RE; Walker JS; Klein F; Rosenwald AJ; Jones WI
Fed Proc; 1967 Sep; 26(5):1558-62. PubMed ID: 4963771
[No Abstract] [Full Text] [Related]
11. Antipyrine metabolism during hepatic regeneration in the rat.
Poulsen HE; Pilsgaard H
Liver; 1985 Aug; 5(4):196-9. PubMed ID: 4058271
[TBL] [Abstract][Full Text] [Related]
12. Distribution of antipyrine, phenylbutazone and phenytoin in experimental renal failure.
Van Peer AP; Belpaire FM; Rosseel MT; Bogaert MG
Pharmacology; 1981; 22(2):139-45. PubMed ID: 7208595
[TBL] [Abstract][Full Text] [Related]
13. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
Saitoh T; Kokue E; Shimoda M
J Vet Pharmacol Ther; 2000 Jun; 23(3):153-8. PubMed ID: 11110102
[TBL] [Abstract][Full Text] [Related]
14. Concurrent bromosulphophthalein and antipyrine administration to assess liver blood flow and hepatic enzymes in rats.
Kaka JS
Food Chem Toxicol; 1991 Jun; 29(6):419-23. PubMed ID: 1874471
[TBL] [Abstract][Full Text] [Related]
15. [Lipoproteins of various experimental animals].
Nagase S
Saishin Igaku; 1972 Mar; 27(3):482-90. PubMed ID: 4623235
[No Abstract] [Full Text] [Related]
16. One sample antipyrine clearance after 90% partial hepatectomy in the rat.
Poulsen HE
Liver; 1985 Aug; 5(4):200-4. PubMed ID: 4058272
[TBL] [Abstract][Full Text] [Related]
17. Microsomal metabolism of antipyrine in rats treated with antineoplastic drugs.
Slørdal L; Høyem-Johansen T; Aarbakke J
Pharmacology; 1983; 26(2):95-9. PubMed ID: 6844394
[TBL] [Abstract][Full Text] [Related]
18. Liver volume, portal vein flow, and clearance of indocyanine green and antipyrine in hyperthyroidism before and after antithyroid treatment.
Andersen V; Sonne J; Court-Payen M; Sletting S; Prip A; Mølholm Hansen J
Scand J Gastroenterol; 1999 Jun; 34(6):618-22. PubMed ID: 10440613
[TBL] [Abstract][Full Text] [Related]
19. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease.
Homeida M; Roberts CJ; Halliwell M; Read AE; Branch RA
Gut; 1979 Jul; 20(7):596-601. PubMed ID: 488757
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Lean Liver Volume as a Potential Scaler for
Sinha J; Duffull SB; Green B; Al-Sallami HS
Curr Drug Metab; 2020; 21(10):746-750. PubMed ID: 32410559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
